Soleus Capital Master Fund, L.P., 10% Owner at Lyra Therapeutics, Inc. (LYRA), sold 16,909 shares at $16.00 ($271K) on 2020-05-05, disclosed to the SEC on 2020-05-15.
Open-market sale of $271k LYRA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.